Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment-Reference-Cited by-同舟云学术

Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment

Published:2021-08 Issue: Volume: Page:
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Jomrich Gerd,Kollmann Dagmar,Ramazanova Dariga,Ristl Robin,Grose Richard P.,Ilhan-Mutlu Aysegül,Preusser Matthias,Fassnacht Christina^ORCID,Tsai Yi-Chien,Guenova Emmanuella,Schoppmann Sebastian F.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference50 articles.

1. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014;Morgan;Gut,2020

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J Clin,2018

3. Global burden of oesophageal and gastric cancer by histology and subsite in 2018;Arnold;Gut,2020

4. Clinical results of proton beam therapy for esophageal cancer: multicenter retrospective study in Japan;Ono;Cancers,2019

5. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving perspectives regarding the role of the PD-1/PD-L1 pathway in gastric cancer immunotherapy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

2. A practical approach for PD-L1 evaluation in gastroesophageal cancer;Pathologica;2023-04

3. The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors;Frontiers in Oncology;2022-11-08